SCHEMBL4762218

SCHEMBL4762218

NC(=O)Cc1ccc(-c2ccnc(Nc3cccc(N4CCCCC4)c3)n2)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 8/20 0.70
HDAC1 Q13547 2/20 0.65
HDAC6 Q9UBN7 2/20 0.65
CAMK2D Q13557 3/20 0.60
JAK3 P52333 2/20 0.55
ABL1 P00519 1/20 0.53
BCR P11274 1/20 0.53
CDK1 P06493 4/20 0.51
CDK2 P24941 3/20 0.51
MTOR P42345 1/20 0.51
SMG1 Q96Q15 1/20 0.51
GSK3B P49841 3/20 0.50
MAPK8 P45983 2/20 0.50
PIK3CG P48736 2/20 0.50
CAMKK2 Q96RR4 2/20 0.50
FLT3 P36888 5/20 0.49
PLK4 O00444 1/20 0.49
CHEK1 O14757 1/20 0.49
PRKD3 O94806 1/20 0.49
LCK P06239 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4828753 0.88 JAK2 (0.55) JAK2HDAC1HDAC6CAMK2DJAK3
SCHEMBL4603072 0.87 JAK2 (0.54) JAK2HDAC1HDAC6CAMK2DJAK3
SCHEMBL4603101 0.85 JAK2 (0.55) JAK2HDAC1HDAC6CAMK2DJAK3
SCHEMBL4376645 0.83 JAK2 (1.00) JAK2HDAC1HDAC6CAMK2DJAK3
SCHEMBL4600894 0.78 CCNT1 (0.51) JAK2CAMK2DJAK3ABL1BCR
SCHEMBL4584094 0.77 JAK2 (0.59) JAK2HDAC1HDAC6CAMK2DJAK3
SCHEMBL4602091 0.77 GSK3B (0.57) JAK2HDAC1HDAC6JAK3GSK3B
SCHEMBL3753315 0.77 MAPK8 (0.62) JAK2CAMK2DJAK3ABL1BCR
SCHEMBL3759170 0.76 MAPK8 (0.71) JAK2HDAC1HDAC6CAMK2DJAK3
SCHEMBL27388317 0.76 JAK2 (0.71) JAK2HDAC1HDAC6CAMK2DJAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1979329-A2 4-ARYL-2-AMINO-PYRIMIDINES OR 4-ARYL-2-AMINOALKYL-PYRIMIDINES AS JAK-2 MODULATORS AND METHODS OF USE Exelixis, Inc. (US) 2008-10-15 EP disclosed
WO-2007089768-A2 4-ARYL-2-AMINO-PYRIMIDINES OR 4-ARYL-2-AMINOALKYL-PYRIMIDINES AS JAK-2 MODULATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM EXELIXIS, INC. (US) 2007-08-09 WO disclosed